More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$216434008
EPS
-0.13
P/E ratio
--
Price to sales
4.02
Dividend yield
--
Beta
0.464147
Previous close
$6.40
Today's open
$6.40
Day's range
$5.93 - $6.40
52 week range
$1.81 - $9.34
show more
CEO
Kevin J. Knopp
Employees
246
Headquarters
Burlington, MA
Exchange
NASDAQ Global Market
Shares outstanding
36192978
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
Seeking Alpha • Nov 10, 2025

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. “We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life,” said Kevin J. Knopp, CEO and Co-founder. “Revenue for the f.
Business Wire • Nov 10, 2025

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.23 per share a year ago.
Zacks Investment Research • Nov 10, 2025

Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • Nov 4, 2025

908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Wednesday, November 12 at 8:40 a.m. Eastern Time 27th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Thursday, November 20 at 10 a.m. Cen.
Business Wire • Oct 30, 2025

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification
BOSTON--(BUSINESS WIRE)-- #CoastGuard--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Coast Guard purchased 23 of the company's MX908 devices for narcotics interdiction efforts and hazardous threat detection, helping to safeguard ports, waterways and coastal communities. With this purchase, the Coast Guard is now fielding more than 35 MX908 devices across the maritime environment. Within the Coast Guard highly trained units.
Business Wire • Oct 28, 2025

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available.
Business Wire • Oct 22, 2025

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 of the company's XplorIR devices for the chemical identification and quantification of hazardous gases and vapors. The program's mission is to support federal firefighters, military police, post offices and security augmentation forces with CBRNE (Chemical, Biological, Rad.
Business Wire • Oct 16, 2025

908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Investment Research • Sep 22, 2025

908 Devices (MASS) Q2 Revenue Jumps 14%
908 Devices (MASS) Q2 Revenue Jumps 14%
The Motley Fool • Aug 6, 2025

¹ Disclosures

Open an M1 investment account to buy and sell 908 Devices Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.